Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Rabitsch, W; Knöbl, P; Prinz, E; Keil, F; Greinix, H; Kalhs, P; Worel, N; Jansen, M; Hörl, WH; Derfler, K.
Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Bone Marrow Transplant. 2003; 32(10):1015-1019 Doi: 10.1038/sj.bmt.1704264 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Greinix Hildegard
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Delayed donor red cell engraftment and prolonged red cell aplasia (PRCA) are well-recognized complications of major ABO-incompatible myeloablative and non-myeloablative hematopoietic stem cell transplantation (HSCT). There is an intense debate about the impact on outcome, severity of hemolysis, association with graft-versus-host disease and survival after blood group-incompatible stem cell transplantation. Therefore, therapeutic strategies should be considered to avoid these possible complications. We present five patients, who received allogeneic HSCT from human leukocyte antigen-identical donors for hematological malignancies, which were treated with Ig-Therasorb immunoadsorption (five treatments/week) to remove persisting incompatible isohemagglutinins. After a median of 17 treatments (range 9-25), all the patients became transfusion independent with the presentation of donor's blood group. No side effects occurred during treatment. Ig-Therasorb immunoadsorption seems to be a promising therapeutic method for rapid, efficient and safe elimination for persisting isohemagglutinins for patients with PRCA after allogeneic hematological stem cell transplantation.
Find related publications in this database (using NLM MeSH Indexing)
ABO Blood-Group System - immunology
Adult -
Blood Group Incompatibility -
Female -
Hemagglutinins - isolation & purification
Hematologic Neoplasms - complications Hematologic Neoplasms - therapy
Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods
Histocompatibility -
Humans -
Immunosorbent Techniques -
Male -
Middle Aged -
Red-Cell Aplasia, Pure - etiology Red-Cell Aplasia, Pure - therapy
Transplantation, Homologous -
Treatment Outcome -

Find related publications in this database (Keywords)
red cell aplasia
stem cell transplantation
immunoadsorption
© Med Uni Graz Impressum